UBS Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Sell
29,100
-900
-3% -$71K ﹤0.01% 4945
2025
Q4
$2.46M Hold
30,000
﹤0.01% 4771
2025
Q3
$2.25M Hold
30,000
﹤0.01% 4834
2025
Q2
$2.22M Buy
30,000
+3,000
+11% +$209K ﹤0.01% 4703
2025
Q1
$2.18M Sell
27,000
-700,400
-96% -$60.2M ﹤0.01% 4629
2024
Q4
$56.9M Buy
727,400
+247,800
+52% +$21.1M 0.01% 1346
2024
Q3
$45M Buy
479,600
+378,100
+373% +$31.7M 0.01% 1218
2024
Q2
$7.91M Hold
101,500
﹤0.01% 2431
2024
Q1
$9.23M Buy
+101,500
New +$8.45M ﹤0.01% 2345

Other funds holding GEHC

UBS Group's GEHC Position: Q1 2026 in Review

UBS Group reduced its GE HealthCare (GEHC) stake by 1.5% in Q1 2026, selling an estimated $3.34M and leaving 2,805,315 shares worth $200M. The position accounts for 0.03% of the portfolio, ranked #616.

UBS Group first reported a position in GEHC in Q4 2022 and has held it in 14 quarters since. The position peaked at $309M in Q4 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • UBS Group held 2,805,315 shares of GE HealthCare worth $200M as of Q1 2026.
  • UBS Group sold 42,397 GE HealthCare shares in Q1 2026, an estimated $3.34M.
  • GE HealthCare made up 0.03% of UBS Group's portfolio in Q1 2026, its #616 holding.
  • UBS Group first reported a position in GE HealthCare in Q4 2022 and has held it in 14 quarters since.
  • UBS Group's GE HealthCare position peaked at $309M in Q4 2024.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.